As of 2025-09-19, the Intrinsic Value of Abivax SA (ABVX.PA) is -15.13 EUR. This ABVX.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 69.90 EUR, the upside of Abivax SA is -121.64%.
Based on its market price of 69.90 EUR and our intrinsic valuation, Abivax SA (ABVX.PA) is overvalued by 121.64%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -15.13 - -15.13 | -15.13 | -121.64% |
| P/E | (12.34) - (18.45) | (13.01) | -118.6% |
| DDM - Stable | (24.83) - (91.43) | (58.13) | -183.2% |
| DDM - Multi | (16.93) - (50.18) | (25.53) | -136.5% |
| Market Cap (mil) | 5,282.34 |
| Beta | 1.76 |
| Outstanding shares (mil) | 75.57 |
| Enterprise Value (mil) | 5,271.32 |
| Market risk premium | 5.82% |
| Cost of Equity | 9.75% |
| Cost of Debt | 5.00% |
| WACC | 9.66% |